PC
TECX

PointState Capital’s Tectonic Therapeutic TECX Stock Holding History

PointState Capital’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-9,063
Closed -$5.64M – 143
2018
Q3 		$5.64M Sell
9,063
-3,020
-25% -$1.34M 0.07% 92
2018
Q2 		$4.14M Buy
+12,083
New +$4.36M 0.05% 125

Other funds holding TECX

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PointState Capital's TECX Position: Q4 2018 in Review

PointState Capital sold out of Tectonic Therapeutic (TECX) in Q4 2018, closing a stake of 9,063 shares — an estimated $5.64M sold.

PointState Capital first reported a position in TECX in Q2 2018 and held it in 2 quarters. The position peaked at $5.64M in Q3 2018. 59 funds tracked by Wall St. Rank hold TECX as of Q4 2018.

  • PointState Capital reported no remaining Tectonic Therapeutic position as of Q4 2018 after selling out during the quarter.
  • PointState Capital sold 9,063 Tectonic Therapeutic shares in Q4 2018, an estimated $5.64M.
  • PointState Capital first reported a position in Tectonic Therapeutic in Q2 2018 and held it in 2 quarters.
  • PointState Capital's Tectonic Therapeutic position peaked at $5.64M in Q3 2018.
  • 59 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2018.

Based on PointState Capital's 13F filing for Q4 2018, filed 14 Feb 2019.